BiotechTubeBiotechTube
Home/Theravance Biopharma/Laurie Smaldone Alsup
LS

Laurie Smaldone Alsup

Director

Theravance Biopharma

Therapeutic Areas

RespiratoryChronic Obstructive Pulmonary Disease (COPD)

Theravance Biopharma Pipeline

DrugIndicationPhase
YUPELRI® (revefenacin)Maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD)Approved
TD-0903Inflammatory Lung Disease (e.g., previously COVID-19)Phase 2
Nebulized Lung-Selective BispecificsSerious Respiratory DiseasesPreclinical
Oral Lung-Selective BispecificsSerious Respiratory DiseasesPreclinical

Leadership Team at Theravance Biopharma

RE
Rick E Winningham
Chief Executive Officer
RF
Rhonda F. Farnum
Senior Vice President, Commercial and Medical Affairs and Chief Business Officer
BG
Brett Grimaud
Senior Vice President, General Counsel and Secretary
View full Theravance Biopharma profile